Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
La Revue De Medecine Interne|July 31, 2003
[HIV1-associated CD4 T lymphocyte apoptosis]J-D Lelièvre, D Arnoult, F Petit, et al.
HIV Medicine|May 18, 2019
Planning HIV therapy to prevent future comorbidities: patient years for tenofovir alafenamideS D Shafran, G Di Perri, S Esser, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 12, 2002
Possible mechanism of toxicity of zidovudine by induction of apoptosis of CD4+ and CD8+ T-cells in vivoO Benveniste, J Estaquier, J D Lelièvre, et al.
Cell Death and Differentiation|May 1, 2004
A novel mechanism for HIV1-mediated bystander CD4+ T-cell death: neighboring dying cells drive the capacity of HIV1 to kill noncycling primary CD4+ T cellsJ D Lelièvre, F Mammano, D Arnoult, et al.
European Journal of Immunology|December 18, 2001
Role of CD95-activated caspase-1 processing of IL-1beta in TCR-mediated proliferation of HIV-infected CD4(+) T cellsF Petit, J Corbeil, J D Lelièvre, et al.
Scientific Reports|July 19, 2023
Immune response to pertussis vaccine in COPD patientsE Feredj, A Wiedemann, C Krief, et al.
Journal of Immunology Research|July 8, 2026
Dynamics of Circulating Follicular Helper and Regulatory T-Cell Memory Induced by mRNA, Inactivated, and Live-Attenuated VaccinesA China, A Rahman, L Hani, et al.
HIV Medicine|January 29, 2019
Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trialM Matignon, J-D Lelièvre, A Lahiani, et al.
Cell Death and Differentiation|October 25, 2003
Caspase-dependent and -independent T-cell death pathways in pathogenic simian immunodeficiency virus infection: relationship to disease progressionD Arnoult, F Petit, J D Lelièvre, et al.
Journal of Virology|February 11, 2021
A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II TrialY Lévy, C Lacabaratz, E Lhomme, et al.
Pageof 2